Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,299
Total Claims
$148K
Drug Cost
66
Beneficiaries
$2,248
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-59%
Opioid rate vs peers
0.9% vs 2.2% avg
+59%
Cost per patient vs peers
$2,248 vs $1,411 avg
+33%
Brand preference vs peers
14.2% vs 10.6% avg
Opioid Prescribing
0.9%
Opioid Rate
12
Opioid Claims
$72
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 176 claims · $129K
Generic: 1,067 claims · $17K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 25 | $30K |
| Empagliflozin | 38 | $28K |
| Dulaglutide | 14 | $15K |
| Apixaban | 17 | $13K |
| Dapagliflozin Propanediol | 12 | $6,876 |
| Atorvastatin Calcium | 87 | $1,204 |
| Rosuvastatin Calcium | 16 | $1,037 |
| Labetalol Hcl | 19 | $619 |
| Metoprolol Succinate | 31 | $613 |
| Nifedipine | 21 | $586 |
| Amlodipine Besylate | 106 | $562 |
| Losartan Potassium | 80 | $498 |
| Hydralazine Hcl | 28 | $480 |
| Levothyroxine Sodium | 45 | $427 |
| Lisinopril | 47 | $355 |
Prescribing Profile
Patient Profile
71
Avg Age
64%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data